Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00997
|
|||||
| Drug Name |
Methylergonovine
|
|||||
| Synonyms |
(8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide; 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-6-methylergoline-8-carboxamide; 9,10-Didehydro-N-(alpha-(hydroxymethyl)propyl)-6-methyl-ergoline-8-beta-carboxamide; Basofortina; D-Lysergic acid-(+)-butanolamide-(2); D-Lysergic acid-dl-hydroxybutylamide-2; Ergotyl; Ergotyl (TN); Lysergic acid butanolamide; ME 277; Metenarin; Methergen; Methergin; Methergine; Methergine (TN); Methylergobasin; Methylergobasine; Methylergobrevin; Methylergometrin; Methylergometrine; Methylergometrine (INN); Methylergometrine [INN:BAN]; Methylergometrine maleate; Methylergometrinum; Methylergometrinum [INN-Latin]; Methylergonovin; Metilergometrina; Metilergometrina [DCIT]; Metilergometrinio; Metilergometrinio [INN-Spanish]; N-(alpha-(Hydroxymethyl)propyl)-D-lysergamide; Partergin; Ryegonovin; Spametrin-M
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Oxytocics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H25N3O2
|
|||||
| Canonical SMILES |
CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C
|
|||||
| InChI |
InChI=1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)/t13-,14+,18-/m1/s1
|
|||||
| InChIKey |
UNBRKDKAWYKMIV-QWQRMKEZSA-N
|
|||||
| CAS Number |
CAS 113-42-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 339.4 | Topological Polar Surface Area | 68.4 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
2.3
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.